Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
The drugmaker said revenue expectations moved higher as its weight-loss and diabetes franchises, anchored by Mounjaro and Zepbound, accounted for nearly two-thirds of a recent quarter’s sales, according to a report.
THE APEX TIMES
THE APEX TIMES
Texas MedClinic, a San Antonio-founded urgent care chain that grew to 40 locations across the Alamo City, Austin and Houston metro areas, is transitioning its clinics following HCA Healthcare’s acquisition, according to a report published this week.
THE APEX TIMES
A new collaboration between CVS Health and Eli Lilly is aimed at improving patient access to GLP-1 medicines, according to a report cited by Yahoo Finance, in a week when investors also scanned major healthcare names for second-quarter outlines.
THE APEX TIMES
A Yahoo Finance recap summarizes CVS Health’s Q2 2026 earnings call, but provides limited detail on specific operating metrics in the information reviewed for this report.
THE APEX TIMES
CVS Health reported second-quarter net income of $2.9 billion, nearly tripling from the year-ago period, citing improvements in how it is managing costs tied to its Aetna health plan.
THE APEX TIMES
A new market note argues that UnitedHealth’s stock upside hinges less on growth and more on narrowing the gap between revenue performance and operating margin.
THE APEX TIMES
CVS Health increased its full-year earnings guidance following a second-quarter report that outperformed analysts’ expectations. Despite the upgrade, the stock dropped sharply in early trading on Wednesday.
THE APEX TIMES
Eli Lilly reported a strong second quarter driven by continued demand for its GLP-1 portfolio, but a single open question is shaping how investors interpret the results.
THE APEX TIMES
A market-focused roundup tied Gilead’s “uncertain” near-term outlook, Merck’s PCSK9 launch risk, and a potential trial readout that could reshape Pfizer’s trajectory in the coming quarters.
